New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia

Infection, Genetics and Evolution

Volumn 12, Issue 3, 2012, Pages 549-556

  Varghese, Bright ^a   Hillemann, Andreas ^b   Wijayanti, Dian Rachma ^c   Shoukri, Mohammed ^a   Al rabiah, Fahad ^a   Al Omari, Ruba ^a   Al Hajoj, Sahal ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b HAIN LIFESCIENCE GMBH   (Germany)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Drug resistance; Isoniazid; Mutation; Rifampicin; Saudi Arabia; Tuberculosis

Indexed keywords

BACTERIAL PROTEIN; GENOMIC DNA; ISONIAZID; KATG315 PROTEIN; RIFAMPICIN; RPOB531 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PRIORITY JOURNAL; RPOB531 GENE; SAUDI ARABIA; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; CATALASE; CLUSTER ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENETIC VARIATION; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; RIFAMPIN; SAUDI ARABIA; TUBERCULOSIS; YOUNG ADULT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84858863942     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.01.024     Document Type: Article

References (48)

1. Al-Hajoj S.A., Zozio T., Al-Rabiah F., Mohammad V., Al-Nasser M., Sola C., Rastogi N. First insight into the population structure of Mycobacterium tuberculosis in Saudi Arabia. J. Clin. Microbiol. 2007, 45:2467-2473.
2. Al-Hajoj S.A., Rastogi N. The emergence of Beijing genotype of Mycobacterium tuberculosis in the Kingdom of Saudi Arabia. Ann. Thorac. Med. 2010, 5:149-152.
3. Al Kassimi F.A., Abdullah A.K., Al-Hajjaj M.S., Al-Orainey I.O., Bamgboye E.A., Chowdhury M.N. Nationwide community survey of tuberculosis epidemiology in Saudi Arabia. Tuberc. Lung Dis. 1993, 74:254-260.
4. Allix-Beguec C., Harmsen D., Weniger T., Supply P., Niemann S. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 2008, 46:2692-2699.
5. Alzeer A., Mashlah A., Fakim N., Al-Sugair N., Al-Hedaithy M., Al-Majed S., Jamjoom G. Tuberculosis is the commonest cause of pneumonia requiring hospitalization during Hajj (pilgrimage to Makkah). J. Infect. 1998, 36:303-306.
6. Ani A., Bruvik T., Okoh Y., Agaba P., Agbaji O., Idoko J., Dahle U.R. Genetic diversity of Mycobacterium tuberculosis complex in Jos. Nigeria. BMC Infect. Dis. 2010, 10:189.
7. Barczak A.K., Domenech P., Boshoff H.I., Reed M.B., Manca C., Kaplan G., Barry C.E. In vivo phenotypic dominance in mouse mixed infections with Mycobacterium tuberculosis clinical isolates. J. Infect. Dis. 2005, 192:600-606.
8. Brown T., Nikolayevskyy V., Velji P., Drobniewski F. Associations between Mycobacterium tuberculosis strains and phenotypes. Emerg. Infect. Dis. 2010, 16:272-280.
9. Chang C.W., Wu M.H., Chuang P.C., Jou R. Characteristics of multidrug-resistant Mycobacterium tuberculosis in Taiwan: a population-based study. Infect. Genet. Evol. 2011, 11:633-639.
10. Chatterjee A., D'Souza D., Vira T., Bamne A., Ambe G.T., Nicol M.P., Wilkinson R.J., Mistry N. Strains of Mycobacterium tuberculosis from western Maharashtra, India, exhibit a high degree of diversity and strain-specific associations with drug resistance, cavitary disease, and treatment failure. J. Clin. Microbiol. 2010, 48:3593-3599.
11. Dalla Costa E.R., Ribeiro M.O., Silva M.S., Arnold L.S., Rostirolla D.C., Cafrune P.I., Espinoza R.C., Palaci M., Telles M.A., Ritacco V., Suffys P.N., Lopes M.L., Campelo C.L., Miranda S.S., Kremer K., da Silva P.E., Fonseca Lde S., Ho J.L., Kritski A.L., Rossetti M.L. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol. 2009, 9:39.
12. Doustdar F., Azar D.K., Farnia P., Bahrmand A.R., Masjedi M.R., Velayati A.A. Mutations in rpoB gene and genotypes of rifampin resistant Mycobacterium tuberculosis isolates in Iran. Tanaffos 2008, 7:11-17.
13. Dymova M.A., Liashenko O.O., Poteiko P.I., Krutko V.S., Khrapov E.A., Filipenko M.L. Genetic variation of Mycobacterium tuberculosis circulating in Kharkiv Oblast, Ukraine. BMC Infect. Dis. 2011, 11:77.
14. Gagneux S., DeRiemer K., Van T., Kato-Maeda M., de Jong B.C., Narayanan S., Nicol M., Niemann S., Kremer K., Gutierrez M.C., Hilty M., Hopewell P.C., Small P.M. Variable host pathogen compatability in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 2006, 103:2869-2873.
15. Hauck Y., Fabre M., Vergnaud G., Soler C., Pourcel C. Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin. J. Antimicrob. Chemother. 2009, 64:259-262.
16. Iwamoto T., Yoshida S., Suzuki K., Tomita M., Fujiyama R., Tanaka N., Kawakami Y., Ito M. Hypervariable loci that enhance the discriminatory ability of newly proposed 15-loci and 24-loci variable-number tandem repeat typing method on Mycobacterium tuberculosis strains predominated by the Beijing family. FEMS Microbiol. Lett. 2007, 270:67-74.
17. Jiao W.W., Mokrousov I., Sun G.Z., Guo Y.J., Vyazovaya A., Narvskaya O., Shen A.D. Evaluation of new variable-number tandem-repeat systems for typing Mycobacterium tuberculosis with Beijing genotype isolates from Beijing. Chin. J. Clin. Microbiol. 2008, 46:1045-1049.
18. Kamerbeek J., Schouls L., Kolk A., van Agterveld M., van Soolingen D., Kuijper S., Bunschoten A., Molhuizen H., Shaw R., Goyal M., van Embden J. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 1997, 35:907-914.
19. Khan M.Y., Kinsara A.J., Osoba A.O., Wali S., Samman Y., Memish Z. Increasing resistance of Mycobacterium tuberculosis to anti-TB drugs in Saudi Arabia. Int. J. Antimicrob. Agents 2001, 17:415-418.
20. Lai C.C., Liu W.L., Tan C.K., Huang Y.C., Chung K.P., Lee M.R., Hsueh P.R. Differences in drug resistance profiles of Mycobacterium tuberculosis isolates causing pulmonary and extrapulmonary tuberculosis in a medical centre in Taiwan, 2000-2010. Int. J. Antimicrob. Agents 2011, 38:125-129.
21. Laurenzo D., Mousa S.A. Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing. Acta Trop. 2011, 119:5-10.
22. Li G.L., Zhao D.F., Xie T., Ju H.F., Mu C., Zhao H., Wang X.X. Molecular characterization of drug-resistant Beijing family isolates of Mycobacterium tuberculosis from Tianjin. Chin. Biomed. Environ. Sci. 2010, 23:188-193.
23. Manabe Y.C., Dannenberg A.M., Tyagi S.K., Hatem C.L., Yoder M., Woolwine S.C., Zook B.C., Pitt M.L., Bishai W.R. Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis. Infect. Immun. 2003, 71:6004-6011.
24. Marais B.J., Victor T.C., Hesseling A.C., Barnard M., Jordaan A., Brittle W., Reuter H., Beyers N., van Helden P.D., Warren R.M., Schaaf H.S. Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J. Clin. Microbiol. 2006, 44:3539-3543.
25. Marquina-Castillo B., Garcia-Garcia L., Ponce-de-Leon A., Jimenez-Corona M.E., Bobadilla-Del Valle M., Cano-Arellano B., Canizales-Quintero S., Martinez-Gamboa A., Kato-Maeda M., Robertson B., Young D., Small P., Schoolnik G., Sifuentes-Osornio J., Hernandez-Pando R. Virulence, immunopathology and transmissibility of selected strains of Mycobacterium tuberculosis in a murine model. Immunology 2009, 128:123-133.
26. Massi M.N., Wahyuni S., Halik H., Yusuf I., Leong F.J., Dick T., Phyu S. Drug resistance among tuberculosis patients attending diagnostic and treatment centres in Makassar, Indonesia. Int. J. Tuberc. Lung Dis. 2011, 15:489-495.
27. Merza M.A., Farnia P., Tabarsi P., Khazampour M., Masjedi M.R., Velayati A.A. Anti-tuberculosis drug resistance and associated risk factors in a tertiary level TB center in Iran: a retrospective analysis. J. Infect. Dev. Ctries. 2011, 5:511-519.
28. Milaat W.A., Afif H., Ghabrah T. Epidemiology of tuberculosis in Jeddah region, Saudi Arabia. Saudi. Med. J. 1994, 15:133-137.
29. Miotto P., Piana F., Penati V., Canducci F., Migliori G.B., Cirillo D.M. Use of MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains in Italy. J. Clin. Microbiol. 2006, 44:2485-2491.
30. Niemann S., Diel R., Khechinashvili G., Gegia M., Mdivani N., Tang Y.W. Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia. J. Clin. Microbiol. 2010, 48:3544-3550.
31. O'Brien L., Carmichael J., Lowrie D.B., Andrew P.W. Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro. Infect. Immun. 1994, 62:5187-5190.
32. Palomino J.C. Newer diagnostics for tuberculosis and multi-drug resistant tuberculosis. Curr. Opin. Pulm. Med. 2006, 12:172-178.
33. Reed M.B., Domenech P., Manca C., Su H., Barczak A.K., Kreiswirth B.N., Kaplan G., Barry C.E. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004, 431:84-87.
34. Rindi L., Bianchi L., Tortoli E., Lari N., Bonanni D., Garzelli C. Mutations responsible for Mycobacterium tuberculosis isoniazid resistance in Italy. Int. J. Tuberc. Lung Dis. 2005, 9:94-97.
35. Schluger N.W. The impact of drug resistance on the global tuberculosis epidemic. Int. J. Tuberc. Lung Dis. 2000, 4:S71-5.
36. Schneider E., Castro K.G. Tuberculosis trends in the United States, 1992-2001. Tuberculosis (Edinb) 2003, 83:21-29.
37. Shanmugam S., Selvakumar N., Narayanan S. Drug resistance among different genotypes of Mycobacterium tuberculosis isolated from patients from Tiruvallur, South India. Infect. Genet. Evol. 2011, 11:980-986.
38. Sharaf Eldin G.S., Fadl-Elmula I., Ali M.S., Ali A.B., Salih A.L., Mallard K., Bottomley C., McNerney R. Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs. BMC Infect. Dis. 2011, 11:219.
39. Somoskovi A., Parsons L.M., Salfinger M. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir. Res. 2001, 2:164-168.
40. Stavrum R., Myneedu V.P., Arora V.K., Ahmed N., Grewal H.M. In-depth molecular characterization of Mycobacterium tuberculosis from New Delhi - predominance of drug resistant isolates of the 'Modern' (TbD1-) type. PLoS ONE 2009, 4:E4540.
41. Sun Y.J., Lee A.S., Wong S.Y., Heersma H., Kremer K., van Soolingen D., Paton N.I. Genotype and phenotype relationships and transmission analysis of drug-resistant tuberculosis in Singapore. Int. J. Tuberc. Lung Dis. 2007, 11:436-442.
42. Tatar D., Senol G., Cosar D., Ozacar R., Halilcolar H. Patterns of drug resistance in pulmonary tuberculosis cases in the Izmir district. Turkey New Microbiol. 2009, 32:31-37.
43. Valcheva V., Mokrousov I., Narvskaya O., Rastogi N., Markova N. Molecular snapshot of drug-resistant and drug-susceptible Mycobacterium tuberculosis strains circulating in Bulgaria. Infect. Genet. Evol. 2008, 8(5):657-663.
44. Van Deun A., Barrera L., Bastian I., Fattorini L., Hoffmann H., Kam K.M., Rigouts L., Rusch-Gerdes S., Wright A. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J. Clin. Microbiol. 2009, 47:3501-3506.
45. Weniger, T., Krawczyk, J., Supply, P., Niemann, S., Harmsen, D., 2010, MIRU-VNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids. Res. 38, W326-W331.
46. Wilder-Smith A., Foo W., Earnest A., Paton N.I. High risk of Mycobacterium tuberculosis infection during the Hajj pilgrimage. Trop. Med. Int. Health 2005, 10:336-339.
47. World Health Organization. 2011, Global Tuberculosis control Report - 2011. Country Profiles, Saudi Arabia, pp. 171-184.
48. Zhang Y., Telenti A. Genetics of Drug Resistance in Mycobacterium tuberculosis 2000, ASM Press, Washington, DC.